Literature DB >> 1555429

Supply-dependent oxygen consumption and mixed venous oxyhemoglobin saturation during isovolemic hemodilution in pigs.

J Räsänen1.   

Abstract

To assess the responsiveness of mixed venous oximetry under conditions of supply-independent and supply-dependent oxygen consumption, we subjected ten pigs to graded isovolemic hemodilution while measuring cardiopulmonary variables, including oxygen consumption (VO2), oxygen delivery (DO2), and mixed venous oxyhemoglobin saturation (SvO2). Supply-dependent VO2 was reached at an average hemoglobin concentration of 3.9 +/- 0.7 g.dl-1, an SvO2 of 38.2 +/- 8.1 percent, and an oxygen extraction ratio of 0.55 +/- 0.10. The change in SvO2 corresponding to a 100-ml decrease in DO2 was -9.2 +/- 3.7 percent when VO2 was supply-independent and -7.6 +/- 5.2 percent when it was supply-dependent (NS). However, the rate of decline in SvO2 in the supply-dependent range was significantly slower than the rate calculated assuming unchanged VO2 (-32.6 +/- 16.3 percent; p less than 0.01). The results indicate that appearance of supply-dependence of VO2 does not render mixed venous oximetry unresponsive to further deterioration of oxygen supply during isovolemic hemodilution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555429     DOI: 10.1378/chest.101.4.1121

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Brain oxygenation monitored by near-infared spectroscopy during recovery from hemorrhagic shock.

Authors:  Masayasu Arai; Toshiyuki Okutomi; Tomoaki Takenaka; Seiji Kato; Fumio Goto
Journal:  J Anesth       Date:  1996-12       Impact factor: 2.078

Review 2.  [Tolerance to perioperative anemia. Mechanisms, influencing factors and limits].

Authors:  O Habler; J Meier; A Pape; H Kertscho; B Zwissler
Journal:  Anaesthesist       Date:  2006-11       Impact factor: 1.041

3.  [Tolerance to perioperative anemia. Mechanisms, influencing factors and limits].

Authors:  O Habler; J Meier; A Pape; H Kertscho; B Zwissler
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.